All Articles

In this first of a 5-part series, the authors provide the tools for navigators to effectively guide patients through the clinical trial experience.

The Importance of Diversity in Clinical Trials

Clinical Trials

July 2024 Vol 15, No 7

Diverse representation is crucial to ensuring that clinical trial results are applicable to the entire population, not just select groups.

First Look Online

Breaking the Stigma: Rethinking Psychotherapy in Cancer Care

Mental Health

June 2024 Vol 15, No 6

Oncology patients commonly report mental health issues, yet few seek support. How to break the stigma of psychotherapy in cancer care.

Maintaining a Working Knowledge of Evidence-Based Information

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

The Editor’s Take

June 2024 Vol 15, No 6

The promotion of screening and early detection guidelines reflect our commitment to the Oncology Navigation Standards of Professional Practice.

Supporting Patients’ Access to Clinical Trials: Patient- and Caregiver-Reported Needs and Experiences With a Clinical Trial Navigation Service for Hematologic Malignancies

By Maria Sae-Hau, PhD; Caroline B. Husick, MPH; Nikie Sarris Esquivel, MPH; Juliet Sheridan, MPH; Laura Arena, MPH; Leah Szumita, MS, RN, CCRN, ACNS-BC; Elisa S. Weiss, PhD

Original Research, Clinical Trials

June 2024 Vol 15, No 6

Amid low enrollment rates, this navigation initiative effectively provided patients and caregivers support in identifying appropriate clinical trials.

Addressing Cancer Health Disparities: The No One Left Alone Initiative

By Rohan Nadkarni; Arva Patel; Warner Kornberg; Asutosh Gor, MD; Sashi Naidu, MD; Viral Rabara, MD; Niyati Nathwani, MD; Kashyap Patel, MD

Health Disparities

June 2024 Vol 15, No 6

A local approach to mitigating health disparities.

Managing Lymphedema Through Movement

By Jenny Spencer, RN, BSN, OCN, CPT, CETI CES

Side-Effects Management

June 2024 Vol 15, No 6

Muscular contraction aids in lymph movement, making exercise a natural option for decreasing risk of and treating cancer-related lymphedema.

Enhancing Patient Care Through Industry Collaboration

Highlights From AONN+, Navigation

June 2024 Vol 15, No 6

Oncology nurse educators and reimbursement field managers representing pharma are an invaluable resource for navigators.

The Lonely City

The Gallery

June 2024 Vol 15, No 6

Oncology social worker, AONN+ member, osteosarcoma survivor, and artist Deysi Barzallo shares her beautiful works of art as the JONS Artist in Residency.

Best Practices in Breast Cancer Therapy | OFS

Highlights of Expert Commentary of OFS

Best Practices

Video Library

In this final video, Polly Niravath, MD, Abbey Kaler, APRN, FNP-C, CMSRN, and Emily Beard, RN, BSN, OCN, CBCN, CG, discuss the clinical features of premenopausal women with breast cancer who may be suitable for treatment with ovarian function suppression (OFS) therapy, effective use of OFS therapy, and relevant navigation strategies used to address the potential challenges associated with OFS treatment.

All Articles

Page 22 of 283

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.